University Hospital’s Case Medical Center researchers are to begin evaluating the ability of the patient’s own stem cells [autologous stem cells] to prevent leg amputations in peripheral arterial disease. PAD effects more than 5 million adults in the US alone. Dr. Vik Kashyap, the leading researcher, explained, "This trial offers an opportunity to save a patient's leg when there are no remaining options to improve blood supply.”
Stem cell based treatments are moving out of the research labs and into the clinical trial phase with steadily increasing frequency. We believe the emerging gold standard in regenerative medical treatments will utilized the patient’s own, autologous, stem cells. To learn more about the utility of dental pulp stem cells in emerging regenerative therapies and to learn how to bank your own valuable stem cells, visit StemSave or call 877-783-6728 (877-StemSave) today.
To view the full article, click here.
The future of Regenerative Medicine is now™.